Kanamycin
Molecular Formula: C18H36N4O1
CAS Number: 8063-07-8
Appearance: White Crystalline powder
ASSAY: 80% MIN, 95% MIN
Description: Kanamycin is an aminoglycoside antibiotic produced by Streptomyces kanamyceticus. It works by inhibiting bacterial protein synthesis, thereby exerting bactericidal effects against a wide range of gram-negative and some gram-positive bacteria.
Category: Antibiotic medication, specifically an aminoglycoside antibiotic.
Use: Kanamycin is used to treat various bacterial infections, including those caused by susceptible strains of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Mycobacterium tuberculosis. It is particularly effective against infections that are resistant to other antibiotics.
Dosage & Administration: Kanamycin is typically administered parenterally (via injection) due to poor oral absorption. The dosage and administration route depend on factors such as the type and severity of the infection, the patient’s age, weight, renal function, and the specific susceptibility of the causative organism. Dosage regimens should be determined by a healthcare professional and adjusted as necessary based on clinical response and monitoring of serum drug levels to minimize the risk of toxicity.
Package Size: Kanamycin is available in various package sizes depending on the manufacturer and formulation. It may be supplied as a powder for reconstitution for injection or as a pre-filled solution for injection. Package sizes can vary from single-dose vials or ampules to multi-dose vials for institutional use. The specific package size and concentration may vary based on the intended use and prescribing practices of healthcare providers.
MOQ: 25KG
Molecular Formula: C18H36N4O1
CAS Number: 8063-07-8
Appearance: White Crystalline powder
ASSAY: 80% MIN, 95% MIN
Description: Kanamycin is an aminoglycoside antibiotic produced by Streptomyces kanamyceticus. It works by inhibiting bacterial protein synthesis, thereby exerting bactericidal effects against a wide range of gram-negative and some gram-positive bacteria.
Category: Antibiotic medication, specifically an aminoglycoside antibiotic.
Use: Kanamycin is used to treat various bacterial infections, including those caused by susceptible strains of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Mycobacterium tuberculosis. It is particularly effective against infections that are resistant to other antibiotics.
Dosage & Administration: Kanamycin is typically administered parenterally (via injection) due to poor oral absorption. The dosage and administration route depend on factors such as the type and severity of the infection, the patient’s age, weight, renal function, and the specific susceptibility of the causative organism. Dosage regimens should be determined by a healthcare professional and adjusted as necessary based on clinical response and monitoring of serum drug levels to minimize the risk of toxicity.
Package Size: Kanamycin is available in various package sizes depending on the manufacturer and formulation. It may be supplied as a powder for reconstitution for injection or as a pre-filled solution for injection. Package sizes can vary from single-dose vials or ampules to multi-dose vials for institutional use. The specific package size and concentration may vary based on the intended use and prescribing practices of healthcare providers.
MOQ: 25KG
